Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.
Chen-Hua LiuH-Y SunChun-Jen LiuW-H ShengS-M HsiehY-C LoW-C LiuT-H SuH-C YangC-M HongT-C TsengP-J ChenD-S ChenChien-Ching HungJia-Horng KaoPublished in: Alimentary pharmacology & therapeutics (2018)
Generic VEL/SOF-based therapy is well-tolerated and provides comparably high SVR12 rates for HCV infection in patients with and without HIV coinfection.